Physician Case Studies

Studies to Come...

"We are both very grateful for this wonderful healing."

~ Dr. Jo Linmans

Belgium

Hyperthyroidism Case Report:

In July 2015, my wife Claudia was diagnosed with a type of hyperthyroidism called Graves' disease. This is an autoimmune disease caused by an antibody called the TSH receptor antibody (TRAb).

 

These antibodies cause the thyroid gland to produce excess thyroid hormone T4 and T3. As a result, the thyroid gland is working too fast and causes following symptoms: irritability, muscle weakness, sleeping problems, fast heartbeat (palpitation), trembling of hands, intolerance of heat, extreme weakness, weight loss despite ravenous appetite, changes in the menstrual cycle, and enlargement of the thyroid gland. Claudia had all of them!

 

The blood results in July 2015 showed very low TSH, high levels of T3 and T4, and very high TRAb levels:

 

  • TSH — 0.01 (Normal = 0.3 - 4.5 mE/L)

  • Free — T3 + 15.23 (Normal = 3.23 - 6.47 pmol/L)

  • Free — T4 + 36.61 (Normal = 9.03 - 23.22 pmol/L)

  • TRAb ++ 4.1 (Normal = 0 - 1 U/L)

 

There are three main treatment options: medications, radioiodine therapy, or thyroid surgery if the first options do not work. I started to treat Claudia with the drug Strumazol at 3 tablets per day to block the formation of T4, which is only to treat the symptoms. A beta blocker was also added to the treatment to slow down her rapid heartbeat. With these drugs, her symptoms became partly under control but her condition was not cured. As long as the antibody TRAb is elevated, the disease is active.

 

This treatment is typically continued for up to two years. If during this time the TRAb goes back to normal levels the treatment is stopped. That happens in 50 percent of patients. The other 50 percent need either radioiodine therapy or surgery to have the thyroid removed. With either choice, the patient then needs a lifelong substitution of thyroid hormone. Understandably, we did not want the last two options!

 

Besides the conventional treatment, Claudia started complementary treatments: Homeopathy, food supplements, nutrition adjustments, frequency medicine, etc. As an RSE student, Claudia also started focusing on healing her thyroid gland.

 

From July 2015 to March 2016, blood investigations where done every month. The TRAb stayed elevated during that period with only two short periods when the value of the TRAb dropped to normal for only a short period of time and then elevated again.

 

In February 2016, we got the announcement of the opening of the first Blu Room in Europe. I immediately took the opportunity and booked for 4 days Blu Room retreat in Bad Mergentheim, Germany in March 2016. In those 4 days, Claudia went 5 times to the Blu Room focusing on healing.

 

In April 2016 (one month after her Blu Room sessions), the blood result showed normal rates of TRAb! This time the normal values of the TRAb persisted over the next several months which gave me the opportunity to gradually wean her off the Strumazol and the beta blocker. All of her symptoms gradually diminished and she regained normal and optimal health. Since her healing, Claudia visited the Blu Room in Italy once and recently a few times to the Blu Room in Mülheim, Germany.

From April 2016 to September 2017, blood investigations were done on a regular base. Her thyroid function stayed optimal and the TRAb values stayed normal the whole time. The last blood results date from September 2017:

 

  • TSH — 0.82 (Normal = 0.3 - 4.5 mE/L)

  • free — T3 5.11 (Normal = 3.23 - 6.47 pmol/L)

  • free — T4 16.90 (Normal = 9.03 - 23.22 pmol/L)

  • TRAb <0.3 (Normal = 0 - 1 U/L)

We now have a 1.5 years of follow-up after the healing with no relapse of the disease. Claudia's symptoms are all gone and that she is in good health.

We are both very grateful for this wonderful healing.

Dr. Jo Linmans (MD)
Belgium

  • Facebook
  • YouTube

© 2019 Blu Room Enterprises, LLC.  All rights reserved. Legal information.

Blu Room® is an internationally registered trade and service mark of JZ Knight, used with permission.

 

US Patent 9,919,162